This is not the most recent version of the article. View current version (15 DEC 2015)

Intervention Review

You have free access to this content

Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients

  1. Marcus Weitz1,*,
  2. Brigitte Strahm2,
  3. Joerg J Meerpohl3,
  4. Dirk Bassler4

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 25 FEB 2014

Assessed as up-to-date: 11 MAR 2013

DOI: 10.1002/14651858.CD009898.pub2


How to Cite

Weitz M, Strahm B, Meerpohl JJ, Bassler D. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD009898. DOI: 10.1002/14651858.CD009898.pub2.

Author Information

  1. 1

    University of Tuebingen, Department of Pediatrics, Tübingen, Germany

  2. 2

    University Medical School Freiburg, Pediatric Hematology and Oncology Centre for Pediatrics and Adolescent Medicine, Freiburg, Germany

  3. 3

    Medical Center - University of Freiburg, German Cochrane Centre, Freiburg, Germany

  4. 4

    University Children's Hospital, Department of Neonatology, Tuebingen, Germany

*Marcus Weitz, Pediatric Nephrology, University Children's Hospital, Steinwiesstrasse 75, Zurich, 8032, Switzerland. marcus.weitz@kispi.uzh.ch.

Publication History

  1. Publication Status: New
  2. Published Online: 25 FEB 2014

SEARCH

This is not the most recent version of the article. View current version (15 DEC 2015)

References

References to studies excluded from this review

  1. References to studies excluded from this review
  2. Additional references
Apisarnthanarax 2003 {published data only}
  • Apisarnthanarax N, Donato M, Korbling M, Couriel D, Gajewski J, Giralt S, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplantation 2003;31(6):459-65.
Balda 1996 {published data only}
  • Balda B, Konstantinov A, Starz H, Gneklow A, Heidemann P. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft versus host disease. Journal of the European Academy of Dermatology and Venereology 1996;7:155-62.
Besnier 1997 {published data only}
  • Besnier DP, Chabannes D, Mahe B, Mussini JM, Baranger TA, Muller JY, et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation 1997;64(1):49-54.
Biagi 2000 {published data only}
  • Biagi E, Perseghin P, Buscemi F, Dassi M, Rovelli A, Balduzzi A. Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease. Haematologica 2000;85(3):329-30.
Bisaccia 2011 {published data only}
  • Bisaccia E, Palangio M, Gonzalez J. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease. Transfusion and Apheresis Science 2011;45(2):187-90.
Child 1999 {published data only}
  • Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplantation 1999;23(9):881-7.
D'Incan 2000 {published data only}
  • D'Incan M, Kanold J, Halle P, De Lumley L, Souteyrand P, Demeocq F. Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases. Annales de Dermatologie et de Venereologie 2000;127(2):166-70.
Dall'Amico 1997 {published data only}
  • Dall'Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B, et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. British Journal of Haematology 1997;97(4):848-54.
Flowers 2008 {published data only}
  • Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008;112(7):2667-74.
Foss 2003 {published data only}
  • Foss FM. Extracorporeal photopheresis in the treatment of graft-vs-host disease. Journal of Cutaneous Medicine and Surgery 2003;7(4 Suppl):13-7.
Foss 2005 {published data only}
  • Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplantation 2005;35(12):1187-93.
Halle 2002 {published data only}
  • Halle P, Paillard C, D'Incan M, Bordigoni P, Piguet C, De Lumley L, et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. Journal of Hematotherapy & Stem Cell Research 2002;11(3):501-12.
Kanold 2003 {published data only}
  • Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Demeocq F. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfusion and Apheresis Science 2003;28(1):71-80.
Kanold 2005 {published data only}
  • Kanold J, Messina C, Halle P, Locatelli F, Lanino E, Cesaro S, et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplantation 2005;35(Suppl 1):S69-71.
Kanold 2007 {published data only}
Looks 1996 {published data only}
  • Looks A, Fuchs D, Rulke D, Lange D, Zintl F, Wollina U. Successful treatment of acute graft versus host disease after bone marrow transplantation in 16-year old girl with extracorporeal photopheresis. Onkologie 1996;7:155-62.
Messina 2003 {published data only}
Perotti 1999 {published data only}
  • Perotti C, Torretta L, Viarengo G, Roveda L, Bernuzzi S, Carbone S, et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 1999;84(3):237-41.
Peters 2000 {published data only}
  • Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplantation 2000;26(4):405-11.
Rossetti 1995 {published data only}
  • Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995;59(1):149-51.
Rossetti 1996 {published data only}
  • Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplantation 1996;18(Suppl 2):175-81.
Salvaneschi 2001 {published data only}
Zecca 2000 {published data only}
  • Zecca M, Locatelli F. Management of graft-versus-host disease in paediatric bone marrow transplant recipients. Paediatric Drugs 2000;2(1):29-55.

Additional references

  1. References to studies excluded from this review
  2. Additional references
Akpek 2001
  • Akpek G, Lee SM, Anders V, Vogelsang GB. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2001;7(9):495-502.
Akpek 2003
  • Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003;102(3):802-9.
Allan 2007
  • Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. International Immunology 2007;19(4):345-54.
Arai 2010
  • Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler, et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2010;118(15):4242-49.
Atkinson 1990
  • Atkinson K, Horowitz MM, Gale RP, Van Bekkum DW, Gluckman E, Good RA, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990;75(12):2459-64.
Barrett 2008
Beredjiklian 1998
  • Beredjiklian PK, Drummond DS, Dormans JP, Davidson RS, Brock GT, August C. Orthopaedic manifestations of chronic graft-versus-host disease. Journal of Pediatric Orthopedics 1998;18(5):572-5.
Bethea 1999
  • Bethea D, Fullmer B, Syed S, Seltzer G, Tiano J, Rischko C, et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. Journal of Dermatological Science 1999;19(2):78-88.
Billingham 1966
  • Billingham RE. The biology of graft-versus-host reactions. Harvey Lectures 1966;62:21-78.
Bladon 2006
Bolanos-Meade 2008
Brickl 1984
  • Brickl R, Schmid J, Koss FW. Clinical pharmacology of oral psoralen drugs. Photo-dermatology 1984;1(4):174-86.
Bunin 2008
  • Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, et al. Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. Journal of Clinical Oncology 2008;26(26):4326-32.
Busca 2000
  • Busca A, Saroglia EM, Lanino E, Manfredini L, Uderzo C, Nicolini B, et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplantation 2000;25(10):1067-71.
Cahn 2005
  • Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005;106(4):1495-500.
Chosidow 1992
  • Chosidow O, Bagot M, Vernant JP, Roujeau JC, Cordonnier C, Kuentz M, et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. Journal of the American Academy of Dermatology 1992;26(1):49-55.
Cooke 2009
  • Cooke K, Yanik G. Lung injury following hematopoietic cell transplantation. In: Appelbaum F, Forman S, Negrin R editor(s). Thomas' Hematopoietic Cell Transplantation. 4th Edition. Oxford: Wiley-Blackwell, 2009:1456-72.
Couriel 2006
  • Couriel D, Carpenter PA, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group report. Biology of Blood and Marrow Transplantation 2006;12(4):375-96.
Cutler 2006
Dall'Amico 2002
De Bueger 1993
  • De Bueger M, Bakker A, Bontkes H, van Rood JJ, Goulmy E. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. Bone Marrow Transplantation 1993;11(5):363-8.
Deeks 2011
  • Deeks J, Higgins J, Altman D. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Diaconescu 2005
  • Diaconescu R, Storb R. Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care. Journal of Cancer Research and Clinical Oncology 2005;131(1):1-13.
Dudek 2003
  • Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biology of Blood and Marrow Transplantation 2003;9(10):657-66.
Eapen 2004
  • Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, et al. the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents. Journal of Clinical Oncology 2004;22(24):4872-80.
Edelson 1987
  • Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. New England Journal of Medicine 1987;316(6):297-303.
Ferrara 1991
Ferrara 2004
  • Ferrara JLM. Antin J. The pathophysiology of graft-vs-host disease. In: Blume KG, Forman SJ, Appelbaum FR editor(s). Thomas' Hematopoietic Cell Transplantation. 3rd Edition. Malden, MA: Blackwell Science, 2004:353-68.
Filipovich 2005
  • Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation 2005;11(12):945-56.
Fimiani 2004
Flowers 2002
  • Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100(2):415-9.
Flowers 2011
  • Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Petersdorf EW, Pereira SE, et al. Comparative analysis of risk factors for acute and for chronic graft-versus-host-disease according to National Institute of Health consensus criteria. Blood 2011;117(11):3214-9.
Fraser 2007
Fujii 2008
  • Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 2008;111(6):3276-85.
Gaziev 2010
  • Gaziev J, Lucarelli G. Hematopoietic stem cell transplantation for thalassemia. Current Stem Cell Research and Therapy 2010;6(2):162-9.
Gilman 2000
  • Gilman AL, Chan KW, Mogul A, Morris C, Goldman FD, Boyer M, et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2000;6(3A):327-34.
Gilman 2006
Girardi 2002
  • Girardi M, Schechner J, Glusac E, Berger C, Edelson R. Transimmunization and the evolution of extracorporeal photochemotherapy. Transfusion and Apheresis Science 2002;26(3):181-90.
Goldberg 2003
  • Goldberg JD, Jacobsohn DA, Margolis J, Chen AR, Anders V, Phelps M, et al. Pentostatin for the treatment of chronic graft-versus-host disease in children. Journal of Pediatric Hematology/Oncology 2003;25(7):584-8.
Hackstein 2009
Heald 1989
  • Heald P, Perez M, McKiernan G, Christiensen I, Edelson R. Extracorporeal photochemotherapy: indications, methodology, safety aspects, side effects and long-term results. Photo-dermatology 1989; Vol. 6, issue 4:171-6.
Heshmati 2003
Higgins 2002
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higman 2004
Horowitz 2004
  • Horowitz M. Uses and growth of hematopoietic cell transplantation. In: Forman J AF editor(s). Thomas' Hematopoietic Cell Transplantation. 3rd Edition. Malden, MA: Blackwell Science, 2004:9-15.
Jacobsohn 2009
  • Jacobsohn DA, Gilman AL, Rademaker A, Browning B, Grimley M, Lehmann L, et al. Pediatric Blood and Marrow Transplant Consortium study. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children. Blood 2009;114(20):4354-60.
Jacobsohn 2010
Jagasia 2009
  • Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biology of Blood and Marrow Transplantation 2009; Vol. 15, issue 10:1288-95.
Janin 1994
  • Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O, et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Annals of Internal Medicine 1994; Vol. 120, issue 12:993-8.
Johnston 2005
  • Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2005;11(1):47-55.
Kennedy-Nasser 2006
  • Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biology of Blood and Marrow Transplantation 2006;12(12):1277-84.
Kjaergard 2001
  • Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
Koc 2002
  • Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002;100(1):48-51.
Lamioni 2005
  • Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005;79(7):846-50.
Lee 2003
  • Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2003; Vol. 9, issue 4:215-33.
Legitimo 2007
Lin 2003
  • Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. New England Journal of Medicine 2003;349(23):2201-10.
Lopez 2005
  • Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadhimi Z, Bhatia R, et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2005;11(4):307-13.
Maeda 2005
  • Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. Journal of Immunology 2005;174(10):5968-76.
Martin 2008
  • Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. The Keio Journal of Medicine 2008;57(4):177-83.
Martin 2009
  • Martin PJ, Storer BE, Rowley SD, Flowers ME, Lee SJ, Carpenter PA, et al. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood 2009;113(21):5074-82.
Meisel 2007
  • Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schonberger S, et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biology of Blood and Marrow Transplantation 2007;13(11):1338-45.
Melin-Aldana 2007
  • Melin-Aldana H, Thormann K, Duerst R, Kletzel M, Jacobsohn DA. Hepatitic pattern of graft versus host disease in children. Pediatric Blood and Cancer 2007; Vol. 49, issue 5:727-30.
Miklos 2005
  • Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005;105(7):2973-8.
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Mookerjee 1999
  • Mookerjee B, Altomonte V, Vogelsang G. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation 1999;24(5):517-20.
Mutis 1999
  • Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nature Medicine 1999;5(7):839-42.
Parmar 1998
Pavletic 2005
  • Pavletic SZ, Carter SL, Kernan NA, Henslee-Downey J, Mendizabal AM, Papadopoulos E, et al. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood 2005;106(9):3308-13.
Perotti 2010
Peters 2003
Przepiorka 1995
Ram 2009
Rappeport 2011
  • Rappeport JM, O'Reilly RJ, Kapoor N, Parkman R. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Hematology/Oncology Clinics of North America 2011;25(1):17-30.
RevMan 2011
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rocha 2000
  • Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. New England Journal of Medicine 2000;342(25):1846-54.
Salmasian 2010
  • Salmasian H, Rohanizadegan M, Banihosseini S, Rahimi Darabad R, Rabbani-Anari M, Shakiba A, et al. Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD005565.pub2]
Scarisbrick 2008
Schooneman 2003
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
Shah 2007
  • Shah AJ, Kapoor N, Crooks GM, Weinberg KI, Azim HA, Killen R, et al. The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biology of Blood and Marrow Transplantation 2007;13(5):584-93.
Shimada 2005
  • Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplantation 2005;36(2):115-21.
Shulman 1988
  • Shulman HM, Sullivan KM. Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. Concepts in Immunopathology 1988;6:141-65.
Smith 1998
  • Smith EP, Sniecinski I, Dagis AC, Parker PM, Snyder DS, Stein AS, et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biology of Blood and Marrow Transplantation 1998;4(1):27-37.
Sniecinski 1994
Sterne 2011
  • Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Stewart 2004
Storb 1986
  • Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986;68(1):119-25.
Sullivan 1981
  • Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57(2):267-76.
Sullivan 1988a
  • Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988;72(2):555-61.
Sullivan 1988b
  • Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72(2):546-54.
Sullivan 1991
  • Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology 1991;28(3):250-9.
Sullivan 2004
  • Sullivan K. Graft-versus-host disease. In: Blume KG, Forman SJ, Appelbaum FR editor(s). Thomas Hematopoietic Cell Transplantation. 3rd Edition. Malden, MA: Blackwell Science, 2004:633-64.
Szodoray 2010
  • Szodoray P, Papp G, Nakken B, Harangi M, Zeher M. The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation. Autoimmunity Reviews 2010;9(6):459-64.
Toubai 2008
Treister 2005
  • Treister NS, Woo SB, O'Holleran EW, Lehmann LE, Parsons SK, Guinan EC. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2005;11(9):721-31.
Vogelsang 1992
  • Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE, Jabs DA, et al. Thalidomide for the treatment of chronic graft-versus-host disease. New England Journal of Medicine 1992;326(16):1055-8.
Vogelsang 2001
Voss 2010
  • Voss CY, Fry TJ, Coppes MJ, Blajchman MA. Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis. Transfusion Medicine Reviews 2010;24(1):22-32.
Walters 2000
  • Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000;95(6):1918-24.
Walters 2005
  • Walters MC. Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2005;2005:66-73.
Williamson 2002
Wingard 2002
  • Wingard JR, Vogelsang GB, Deeg HJ. Stem cell transplantation: supportive care and long-term complications. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;2002:422-44.
Wolff 2011
  • Wolff D, Schleuning M, Von Harsdorf S, Bacher U, Gerbitz A, Stadler M, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2011;17(1):1-17.
Xia 2009
  • Xia CQ, Campbell KA, Clare-Salzler MJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Current Opinion in Organ Transplantation 2009;14(4):338-43.
Yoo 1996
  • Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. Journal of Investigative Dermatology 1996;107(2):235-42.
Zecca 2002
  • Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002;100(4):1192-200.
Zhang 2006
  • Zhang C, Todorov I, Zhang Z, Liu Y, Kandeel F, Forman S, et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006;107(7):2993-3001.